Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiron Garcia TrilcefiledCriticalJiron Garcia Trilce
Priority to CR8985ApriorityCriticalpatent/CR8985A/en
Publication of CR8985ApublicationCriticalpatent/CR8985A/en
Un liquido de medicina natural que se utiliza como descongestionante nasal, antiinflamatorio, analgesico y antiseptico para uso humano en las vias respiratorias superiores, con accion bactericida, fungicida y cicatrizante, con la manzanilla (chamaemelum nobile o matricaria recutita) como ingrediente natural al 2% y 100 ml, de agua esteril, mediante el siguiente procedimiento: en 100 ml de agua esteril se diluye la manzanilla al 2%. Luego de envasar presentaciones de 15 ml o de 12 onzas.A natural medicine liquid that is used as a nasal decongestant, anti-inflammatory, analgesic and antiseptic for human use in the upper respiratory tract, with bactericidal, fungicidal and healing action, with chamomile (chamaemelum nobile or matricaria recutita) as a 2% natural ingredient and 100 ml of sterile water, by the following procedure: in 100 ml of sterile water the chamomile is diluted to 2%. After packing 15 ml or 12 ounce presentations.
CR8985A2007-03-082007-03-08
NASAL SPRAY WITH CHAMOMILE
CR8985A
(en)
Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
"NOVEDOUS DERIVATIVES OF ({((3-Methylphenyl) -2H-TETRAZOL-5-IL) -ETOXI} -4H-1,2,4-TRIAZOL-3-IL), PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND MEDICAL USE OF THE SAME" .
USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THIS, FOR THE PREPARATION OF A MEDICINAL PRODUCT TO REGULATE THE LEVEL OF POTASSIUM IN THE BLOOD
Use of a composition comprising nandrolone and a vitamin D compound to prepare a parenteral medicament useful for the treatment or prevention of frailty in an elderly patient; and a composition comprising nandrolone and a vitamin D compound, in a liquid carrier suitable for parenteral administration.